What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey
Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers
Source: ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020
Disease area: Respiratory infections
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Michal Shteinberg, Jeanette Boyd, Stefano Aliberti, Eva Polverino, Bridget Harris, Tove Berg, Annette Posthumus, Thomas Ruddy, Pieter Goeminne, Ernie Lloyd, Timothy Alan, Josje Altenburg, Barbara Crossley, Francesco Blasi, James Chalmers. What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient survey. ERJ Open Res, 7 (1) 00807-2020; 10.1183/23120541.00807-2020
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
What’s important for people with NTM? An EMBARC-ELF patient survey Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020
Nontuberculous mycobacterial disease: an important cause of morbi-mortality in HIV infected subjects Source: Eur Respir J 2003; 22: Suppl. 45, 333s Year: 2003
Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey Source: Eur Respir J, 51 (5) 1702469; 10.1183/13993003.02469-2017 Year: 2018
When is an infectious disease? The clinical spectrum of nontuberculous mycobacterial pulmonary disease Source: International Congress 2019 – New guidelines for treatment of nontuberculous mycobacterial pulmonary disease Year: 2019
Beyond pulmonary nontuberculous mycobacteria disease: do extra-pulmonary forms represent an emerging clinical and public health threat? Source: ERJ Open Res, 3 (3) 00091-2017; 10.1183/23120541.00091-2017 Year: 2017
Patient reported outcomes for non-tuberculous mycobacterial disease Source: Eur Respir J, 55 (1) 1902204; 10.1183/13993003.02204-2019 Year: 2020
The impact of new ATS/IDSA guideline for nontuberculous mycobacterial disease on the diagnosis of nontuberculous mycobacterial lung disease in Korea Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi Year: 2008
When should I suspect NTM disease? Source: ERS Course 2015 Year: 2015
Clinical outcome of multiple nontuberculous mycobacteria infection among people with bronchiectasis in Taiwan: a cohort study Source: Virtual Congress 2020 – New investigations of bronchiectasis and non-tuberculous mycobacteria Year: 2020
Aero-environmental bacteriological survey of respiratory non-tuberculosis mycobacterial disease patients Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections Year: 2016
Looking into real world practice of elder pulmonary non-tuberculous mycobacterial infection. Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
Prevalence of non-tuberculous mycobacterial disease among patients evaluated for pulmonary tuberculosis in Iraq 2015-2018 Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019
How much do patients and doctors know about extrapulmonary tuberculosis? Source: Eur Respir J 2005; 26: Suppl. 49, 416s Year: 2005
Similar characteristics of nontuberculous mycobacterial pulmonary disease in men and women Source: Eur Respir J, 54 (1) 1900252; 10.1183/13993003.00252-2019 Year: 2019
How important is work as a risk for lung infections? A story of tuberculosis and pneumonia Source: Virtual Congress 2020 – How much lung disease is really caused by work, and how to assess the worker who wishes to continue working? Year: 2020
Comparative study of clinical features between elderly and non-elderly patients with pulmonary nontuberculous mycobacterial disease Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021
Pulmonary non-tuberculous mycobacterial infection in patients without predisposing condition, morphological and immunological overview of a french cohort Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021
Long-term follow-up study of patients with pneumoconiosis complicated by nontuberculous mycobacterial lung disease: report of four cases Source: Eur Respir J 2001; 18: Suppl. 33, 443s Year: 2001